Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

US Patent 7026316 · Granted Apr 11, 2006

Estimated economic value: $73,844,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMPK activators2023
Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)2017
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017
Glucagon receptor antagonist compounds, compositions containing such compounds a2017
2-pyridinecarboxamide derivatives, compositions containing such compounds, and m2016
Glucokinase activator compounds, compositions containing such compounds, and met2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2016
Soluble guanylate cyclase activators2016
Glucagon receptor antagonist compounds, compositions containing such compounds a2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2015
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes2015